215 related articles for article (PubMed ID: 10092158)
21. COX-2 inhibitors.
Brooks PM; Day RO
Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
[TBL] [Abstract][Full Text] [Related]
22. Update in rheumatology.
Wernick R; Campbell SM
Ann Intern Med; 2000 Jan; 132(2):125-33. PubMed ID: 10644274
[No Abstract] [Full Text] [Related]
23. Considerations in the use of COX-2 inhibitors in spinal fusion surgery.
Matsumura J
Anesth Analg; 2001 Sep; 93(3):803-4. PubMed ID: 11524365
[No Abstract] [Full Text] [Related]
24. [Cyclooxygenases, structure, biological functions and the role in inflammation processes].
Kotyla PJ; Sliwińska-Kotyla B; Kucharz EJ
Pol Arch Med Wewn; 2001 Oct; 106(4):963-6. PubMed ID: 11993417
[No Abstract] [Full Text] [Related]
25. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
Feldman M; McMahon AT
Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275
[No Abstract] [Full Text] [Related]
26. Specific cyclooxygenase-2 (COX-2) inhibitors.
Rubin BR
J Am Osteopath Assoc; 1999 Jun; 99(6):322-5. PubMed ID: 10405519
[TBL] [Abstract][Full Text] [Related]
27. The unmet anti-inflammatory needs in orthopedics.
Trippel SB
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):3-7. PubMed ID: 10193996
[TBL] [Abstract][Full Text] [Related]
28. COX-2 in large bowel cancer: a one-sided story.
DuBOIS RN
Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
[No Abstract] [Full Text] [Related]
29. The cost of COX inhibitors: how selective should we be?
Marra CA; Esdaile JM; Sun H; Anis AH
J Rheumatol; 2000 Dec; 27(12):2731-3. PubMed ID: 11128654
[No Abstract] [Full Text] [Related]
30. Treatment of rheumatoid arthritis--we're getting closer.
Kushner I; Ballou SP
J Rheumatol; 1999 Nov; 26(11):2291-3. PubMed ID: 10555878
[No Abstract] [Full Text] [Related]
31. The cox-2 inhibitors.
Strassels S
J Mass Dent Soc; 1999; 48(3):43-4. PubMed ID: 10808349
[No Abstract] [Full Text] [Related]
32. COX-2: separating myth from reality.
McKenna F
Scand J Rheumatol Suppl; 1999; 109():19-29. PubMed ID: 10422543
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs)-what makes a NSAID good value for money?
Freemantle N
Rheumatology (Oxford); 2000 Mar; 39(3):232-4. PubMed ID: 10788528
[No Abstract] [Full Text] [Related]
34. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
35. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
Tindall E
J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
[TBL] [Abstract][Full Text] [Related]
36. [Selective cyclooxygenase-2 inhibitor].
Hettich M; Thomae K
Internist (Berl); 1997 Oct; 38(10):1007. PubMed ID: 9432492
[No Abstract] [Full Text] [Related]
37. The promise of coxibs: how far have we progressed?
Schumacher HR
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
[No Abstract] [Full Text] [Related]
38. [Non-steroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors].
Miehle W
Wien Med Wochenschr; 1999; 149(19-20):541-5. PubMed ID: 10637962
[TBL] [Abstract][Full Text] [Related]
39. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
Housholder GT; Chan JT
J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
[No Abstract] [Full Text] [Related]
40. Selective inhibitors of cyclooxygenase-2 (COX-2).
Talley JJ
Prog Med Chem; 1999; 36():201-34. PubMed ID: 10818674
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
